Remedy Pharmaceuticals Receives $2,704,222 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6a946d55-fb0a-4b87-91da-c3b40a4844dc&Preview=1 -
Date
5/23/2012 -
Company Name
Remedy Pharmaceuticals -
Mailing Address
802 6th Avenue New York, NY 10001 -
Company Description
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury. -
Website
http://www.remedypharmaceuticals.com -
Transaction Type
Venture Equity -
Transaction Amount
$2,704,222 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
